https://doi.org/10.4081/monaldi.2021.1617
Single inhaler triple therapy in COPD – all that glitters is not gold
Submitted: September 22, 2020
Accepted: November 30, 2020
Published: April 28, 2021
Accepted: November 30, 2020
Abstract Views: 1170
PDF: 633
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Dear Editor,
The recent studies on combination triple therapy of inhaled corticosteroid, long acting beta2 agonist and long-acting muscarinic antagonist (ICS-LABA-LAMA) in COPD have consistently demonstrated an improvement in exacerbation frequency and/or improvement of lung function...
Lipson DA, Crim C, Criner GJ, et al. Reduction in all-cause mortality with Fluticasone furoate/Umeclidinium/Vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2020;201:1508-16.
DOI: https://doi.org/10.1164/rccm.201911-2207OC
Casas A, Montes de Oca M, Menezes AM, et al. Respiratory medication used in COPD patients from seven latin american countries: the LASSYC study. Int J Chron Obstruct Pulmon Dis 2018;13:1545-56.
DOI: https://doi.org/10.2147/COPD.S154097
Buhl R, Criée C-P, Kardos P, et al. Patients in clinical trials on COPD triple therapy compared to real world populations Am J Respir Crit Care Med 2019;199:A1117.
DOI: https://doi.org/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1117
Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med 2016;4:390-8.
DOI: https://doi.org/10.1016/S2213-2600(16)00100-4
Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65.
DOI: https://doi.org/10.1378/chest.126.1.59
Ferguson GT, Rabe KF, Martinez FJ, et al. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir Med 2018;6:747-8.
DOI: https://doi.org/10.1016/S2213-2600(18)30327-8
Palli SR, Frazer M, DuCharme M, et al. Differences in real-world health and economic outcomes among patients with COPD treated with combination tiotropium/olodaterol versus triple therapy. J Manag Care Spec Pharm 2020;26:1363-74.
DOI: https://doi.org/10.18553/jmcp.2020.20159
Rabe KF, Martinez FJ, Ferguson GT, et al. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD. N Engl J Med 2020;383:35-48.
DOI: https://doi.org/10.1056/NEJMoa1916046
How to Cite
Deshmukh, Kartik, and Arjun Khanna. 2021. “Single Inhaler Triple Therapy in COPD – All That Glitters Is Not Gold”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1617.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- S. Nava, L.M. Fuccella, B. Viglianti, Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD , Monaldi Archives for Chest Disease: Vol. 61 No. 4 (2004): Pulmonary series
- G. Valli, A. Fedeli, R. Antonucci, P. Paoletti, P. Palange, Water and sodium imbalance in COPD patients , Monaldi Archives for Chest Disease: Vol. 61 No. 2 (2004): Pulmonary series
- M. Vitacca, B. Lanini, S. Nava, L. Barbano, R. Porta, E. Clini, N. Ambrosino, Inspiratory muscle workload due to dynamic intrinsic PEEP in stable COPD patients: effects of two different settings of non-invasive pressure-support ventilation , Monaldi Archives for Chest Disease: Vol. 61 No. 2 (2004): Pulmonary series
- A. De Felice, S. Fuschillo, M. Martucci, E. De Angelis, G. Balzano, Euthyroid goitre and sleep apnea , Monaldi Archives for Chest Disease: Vol. 65 No. 1 (2006): Pulmonary series
- Ugo Corrà , Massimo Pistono, Alessandro Mezzani, Marco Gnemmi, Franco Tarro Genta, Roberto Caruso, Pantaleo Giannuzzi, Cardiovascular prevention and rehabilitation for patients with ventricular assist device From exercise therapy to long-term therapy Part I: exercise therapy , Monaldi Archives for Chest Disease: Vol. 76 No. 1 (2011): Cardiac series
- M. Vitacca, L. Bianchi, L. Barbano, N. Ambrosino, Lung and respiratory muscle function at discharge from a respiratory intensive care unit , Monaldi Archives for Chest Disease: Vol. 63 No. 3 (2005): Pulmonary series
- Roberto F.E. Pedretti, Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy? , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- E. Sulu, Özlem Makbule Akbay, Esra Akkutuk Öngel, F. Aksoy, G. Bektemur, Huriye Berk Takir, A. Yilmaz, Castleman’s Disease presenting as a pleural mass in the thoracic cavity , Monaldi Archives for Chest Disease: Vol. 77 No. 3-4 (2012): Pulmonary series
- N. Facciolongo, M. Patelli, S. Gasparini, L. Lazzari Agli, M. Salio, C. Simonassi, B. Del Prato, P. Zanoni, Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies , Monaldi Archives for Chest Disease: Vol. 71 No. 1 (2009): Pulmonary series
- Halil Yanardag, Cuneyt Tetikkurt, Muammer Bilir, Clinical and prognostic significance of muscle biopsy in sarcoidosis , Monaldi Archives for Chest Disease: Vol. 88 No. 1 (2018)
<< < 7 8 9 10 11 12 13 14 15 16 > >>
You may also start an advanced similarity search for this article.
